Rafael Paternostro

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Implementation of specialised care improves survival in patients with amyotrophic lateral sclerosis.

Implementation of specialised care improves survival in patients with amyotrophic lateral sclerosis.

Journal: Neurological research and practice

Published: May 19, 2026

The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD.

The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLD.

Journal: Alimentary pharmacology & therapeutics

Published: August 19, 2025

Bile acid signaling in MASLD: From pathogenesis to therapeutic applications.

Bile acid signaling in MASLD: From pathogenesis to therapeutic applications.

Journal: Hepatology (Baltimore, Md.)

Published: June 28, 2025

The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic review.

The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic review.

Journal: Hepatology communications

Published: December 20, 2024

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

Journal: Journal of hepatology

Published: December 07, 2023

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: November 09, 2023

Letter: NSBB for fatty liver disease-Still a long way to go. Authors' reply.

Letter: NSBB for fatty liver disease-Still a long way to go. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 28, 2023

Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease-Authors' reply.

Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease-Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 28, 2023

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.

Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome.

Journal: Hepatology international

Published: May 05, 2023

Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation.

Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation.

Journal: Alimentary pharmacology & therapeutics

Published: May 05, 2023

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Journal: The lancet. Gastroenterology & hepatology

Published: March 08, 2023

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD.

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD.

Journal: JHEP reports : innovation in hepatology

Published: February 22, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026